Biotech Hangout · Health & Longevity · November 2026
Opler had just published an upbeat State of Biotech report, then watched the biotech index slide. He relays why investors think AI's appetite for capital is crowding out biotech. He calls himself an optimist and expects the slump to pass.
…So with that in mind, that's just a high-level view. I'm going to turn things over to Tim, who again puts out a great periodic report called The State of Biotech. His last report came out, I think, last Friday. So I'm going to pass it over to him on some of his insights. So Tim Opler to you.
Greg, thank you very much. And the report I put out, I think Daphne put a link to it on X. So if you know anyone wants to access it, you can. It's a kind of a long report that really just sort of goes through the whole market. It's very interesting. Bruce Booth also put out a very nice report, which I highly recommend that kind of goes through the whole market as well. And what's nice is the reports are, of course, different. We all have our own perspective. I'm known as being the Oplarbest. So I'm a very optimistic person. And so occasionally I'll go negative on the market. But in that report, I was very upbeat about where biotech is going to go. So that teaches me, right? So since I started to write that report, the XBI is down a full 10 percentage point. So that's actually quite a significant drop in, what, three, four weeks. And so I was talking to some relatively knowledgeable investors in the market yesterday, like what is going on. And I wouldn't say that I heard panic, but I heard like pretty negative sentiment. And, you know, that's obviously not what's going through my head. So like what's happening in the market now? And, you know, we saw the…
Thanks, Tim, for that. Maybe just to throw it out there to our group, how are you all thinking about 2027, especially as we come down to the end of 2026? Do we think that it's going to be as robust of an IPO market and a biotech performance perspective? I could see M ⁇ A at a good pace. In fact, it…
For me, and you would ask me to make a comment about the Anthropic IPO too. I think the main thing that I find difficult to reason through is there's like a whole bunch of biotech specific dynamics. I thought Tim did a really nice job of laying it out. It feels like we are all strapped to a…
Yeah, let me just add to what Matt's saying, because I think he's spot on. So I did a, I was thinking the same themes and I did a quick AI search. So take it with a grain of salt. But I said, what percent of the total U.S. stock market publicly traded companies is represented by the companies that…